technetium fanolesomab trade name neutrospec manufactured palatin technologies mouse monoclonal antibody formerly used aid diagnosis appendicitis labeled radioisotope neutrospec approved us food drug administration fda june imaging patients symptoms appendicitis consisted intact murine mouse igm monoclonal antibody human labeled visible gamma camera image since antibodies bind selectively white blood cells neutrophils could used localize site infection fda received reports palatin deaths lifethreatening adverse events patients received neutrospec events occurred within minutes administration neutrospec included shortness breath low blood pressure cardiopulmonary arrest affected patients required resuscitation intravenous fluids blood pressure support oxygen patients experienced events existing cardiac andor pulmonary conditions may placed higher risk adverse events review postmarketing reports showed additional patients experienced adverse events similar less severe reactions occurred immediately neutrospec marketing product suspended december immune activation dostarlimab ibalizumab